Strength of Wisconsin Biohealth

Digital Health:

Where digital technology meets health solutions. Digital health is empowering patients and healthcare systems to provide personalized care, improve quality, and reduce costs. Digital health is Wisconsin’s newest and fastest growing sector.

Medical Device & Diagnostics:

The medical device and diagnostics industry continues to grow and thrive in Wisconsin, with medical device companies ranging from start-ups to corporate powerhouses choosing to call Wisconsin home.

Health Research Institutes:

Wisconsin boasts some of the nations top research institutes. Wisconsin research institutes received $422 million in NIH funding in 2017 and contributed more than 36,000 jobs in Wisconsin in 2015.

Biotech & Biopharma:

From therapeutic and drug development to translational and integrated science, Wisconsin has it all. Accounting for one of the states’s largest economic drivers, biotech and biopharma continue to flourish in Wisconsin.

Wisconsin: A National Hub for Biomanufacturing

Top Talent. Top Resources. Top Industry.

Innovation. Right here, in Wisconsin.

Marshfield Clinic Research Foundation and Center for Human Genetics are preparing to recruit an additional 80,000 new patients to support President Barack Obama’s Precision Medicine Initiative in an effort to apply genomic discoveries to human health. Read more here. 

Imbed Biosciences today received clearance from the Food and Drug Administration to market its patented wound dressing for human use. The dressing it calls Microlyte Ag is a sheet as thin as Saran Wrap and can conform to the bumps and crevices of a wound. Read more here. 

The Medical College of Wisconsin (MCW) has received two grants totaling $2.8 million to investigate treatments for diseases of the kidney. The first grant is a 5-year, $2.3 million grant from the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases to investigate the development of a drug to treat Type 2 diabetes and metabolic syndrome. The second grant is a one-year $485,000 grant to identify novel therapies for kidney failure in cancer patients. Read more here.

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced that it has entered into a merger agreement with Stratatech Corporation, a privately held regenerative medicine company focused on the development of unique, proprietary skin substitute products. Developmental products include StrataGraft regenerative skin tissue and a technology platform for genetically enhanced skin tissues. Read more here. 



Welcome home: Wisconsin is home to endless outdoor activities throughout all seasons, growing tech & health industries, and a top-tier university system making our home the 8th state in the 2016 Quality of Life list by Forbes.



When industries and instituitions converge and great minds connect, big things happen. Read about collaboration success stories that started right here in Wisconsin and learn how to start your own collaboration story.



Wisconsin boasts both a world-class university system and top-tier talent.  Madison ranks 1st for STEM college graduates. Search our career center for opportunites or find your future hire here:

2015 Wisconsin Bioscience Economic Development Report: Energizing Wisconsin's Economy


Contact our team member Kate at to learn how to get involved!